Matches in Wikidata for { <http://www.wikidata.org/entity/Q104075784> ?p ?o ?g. }
Showing items 1 to 47 of
47
with 100 items per page.
- Q104075784 description "2020 ވަނަ އަހަރުގެ ޑިސެމްބަރުމަހުގެ 2ވަނަ ދުވަހު ޝާއިރުކުރެވުނު ސައިންޓިފިކް ލިޔުމެއް" @default.
- Q104075784 description "artículu científicu espublizáu n'avientu de 2020" @default.
- Q104075784 description "scientific article published on 02 December 2020" @default.
- Q104075784 description "wetenschappelijk artikel" @default.
- Q104075784 description "наукова стаття, опублікована 2 грудня 2020" @default.
- Q104075784 name "Dextran-modified Quercetin-Cu(II)/hyaluronic acid nanomedicine with natural poly(ADP-ribose) polymerase inhibitor and dual targeting for programmed synthetic lethal therapy in triple-negative breast cancer" @default.
- Q104075784 name "Dextran-modified Quercetin-Cu(II)/hyaluronic acid nanomedicine with natural poly(ADP-ribose) polymerase inhibitor and dual targeting for programmed synthetic lethal therapy in triple-negative breast cancer" @default.
- Q104075784 name "Dextran-modified Quercetin-Cu(II)/hyaluronic acid nanomedicine with natural poly(ADP-ribose) polymerase inhibitor and dual targeting for programmed synthetic lethal therapy in triple-negative breast cancer" @default.
- Q104075784 type Item @default.
- Q104075784 label "Dextran-modified Quercetin-Cu(II)/hyaluronic acid nanomedicine with natural poly(ADP-ribose) polymerase inhibitor and dual targeting for programmed synthetic lethal therapy in triple-negative breast cancer" @default.
- Q104075784 label "Dextran-modified Quercetin-Cu(II)/hyaluronic acid nanomedicine with natural poly(ADP-ribose) polymerase inhibitor and dual targeting for programmed synthetic lethal therapy in triple-negative breast cancer" @default.
- Q104075784 label "Dextran-modified Quercetin-Cu(II)/hyaluronic acid nanomedicine with natural poly(ADP-ribose) polymerase inhibitor and dual targeting for programmed synthetic lethal therapy in triple-negative breast cancer" @default.
- Q104075784 prefLabel "Dextran-modified Quercetin-Cu(II)/hyaluronic acid nanomedicine with natural poly(ADP-ribose) polymerase inhibitor and dual targeting for programmed synthetic lethal therapy in triple-negative breast cancer" @default.
- Q104075784 prefLabel "Dextran-modified Quercetin-Cu(II)/hyaluronic acid nanomedicine with natural poly(ADP-ribose) polymerase inhibitor and dual targeting for programmed synthetic lethal therapy in triple-negative breast cancer" @default.
- Q104075784 prefLabel "Dextran-modified Quercetin-Cu(II)/hyaluronic acid nanomedicine with natural poly(ADP-ribose) polymerase inhibitor and dual targeting for programmed synthetic lethal therapy in triple-negative breast cancer" @default.
- Q104075784 P1433 Q104075784-99778238-C6E9-4302-9D8E-F1B0EA479014 @default.
- Q104075784 P1476 Q104075784-A06BE9BB-7A7B-4C59-8BFB-903AE4D6A227 @default.
- Q104075784 P2093 Q104075784-17F48CCC-B6CE-4ED5-A927-FE33EE6D91EC @default.
- Q104075784 P2093 Q104075784-2627CD80-79B6-43C4-81B7-3F3E1C5C5456 @default.
- Q104075784 P2093 Q104075784-4E84A2C6-94BC-4792-BC18-D2C845BC3ABE @default.
- Q104075784 P2093 Q104075784-6FB05FC1-C9BD-4A5F-B0AD-4593C4DC453E @default.
- Q104075784 P2093 Q104075784-98A178C1-0437-437A-A052-2DD148ED6B2E @default.
- Q104075784 P2093 Q104075784-A28F1397-CE68-425E-B8F0-A531D1F9162B @default.
- Q104075784 P2093 Q104075784-BBD587D3-904D-44FA-A7FB-4CBEF52C2F57 @default.
- Q104075784 P31 Q104075784-D60CECB5-4CD1-44A3-BC36-8D8E2E4D8590 @default.
- Q104075784 P356 Q104075784-858F17B0-80A6-42C4-801A-1B77A154D08E @default.
- Q104075784 P577 Q104075784-72ABCC6C-B825-4428-9803-D3358CABCA0A @default.
- Q104075784 P698 Q104075784-2906E819-268E-4135-A751-B48001F08B22 @default.
- Q104075784 P921 Q104075784-78F3A514-24E0-4904-8885-9DF8D8A9B04A @default.
- Q104075784 P921 Q104075784-BD7C3C80-05F6-4EFC-94CE-F57FD60CB03F @default.
- Q104075784 P356 J.JCONREL.2020.11.061 @default.
- Q104075784 P698 33278482 @default.
- Q104075784 P1433 Q6295046 @default.
- Q104075784 P1476 "Dextran-modified Quercetin-Cu(II)/hyaluronic acid nanomedicine with natural poly(ADP-ribose) polymerase inhibitor and dual targeting for programmed synthetic lethal therapy in triple-negative breast cancer" @default.
- Q104075784 P2093 "Chih-Sheng Chiang" @default.
- Q104075784 P2093 "Hsin-Yao Ho" @default.
- Q104075784 P2093 "Hung-Wei Cheng" @default.
- Q104075784 P2093 "San-Yuan Chen" @default.
- Q104075784 P2093 "Syun-Hong Chou" @default.
- Q104075784 P2093 "Woei-Cherng Shyu" @default.
- Q104075784 P2093 "Yen-Ho Lai" @default.
- Q104075784 P31 Q13442814 @default.
- Q104075784 P356 "10.1016/J.JCONREL.2020.11.061" @default.
- Q104075784 P577 "2020-12-02T00:00:00Z" @default.
- Q104075784 P698 "33278482" @default.
- Q104075784 P921 Q261659 @default.
- Q104075784 P921 Q7843332 @default.